<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01176578</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00047188</org_study_id>
    <nct_id>NCT01176578</nct_id>
  </id_info>
  <brief_title>Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes</brief_title>
  <acronym>EPC-DM</acronym>
  <official_title>Exercise Training, CACs, and Vascular Function in Older Veterans With IGT (Impaired Glucose Tolerance)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baltimore VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Baltimore VA Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The discovery of the role of endothelial progenitor cells (EPCs) and their involvement in the
      cardiovascular complications of type 2 diabetes (T2DM) would quickly have a significant
      impact on the millions of Americans who have T2DM. This project is designed to 1) determine
      the mechanisms underlying EPC dysfunction in older, sedentary adults with T2DM compared those
      with normal glucose metabolism and impaired glucose metabolism, and 2) determine if aerobic
      exercise training is an efficacious therapy for EPC dysfunction in T2DM, and whether
      improvement in EPC number and function translates to improved endothelial function, increased
      capillarization, and improved glucose metabolism in T2DM.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2011</start_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial progenitor cell number</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Endothelial progenitor cell number</measure>
    <time_frame>6-month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Skeletal muscle capillarization</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Skeletal muscle capillarization</measure>
    <time_frame>6-month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory Fitness</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory Fitness</measure>
    <time_frame>6-month</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>T2DM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Type 2 Diabetes Mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IGT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Impaired Glucose Tolerance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NGT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal Glucose Tolerance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic Exercise Training</intervention_name>
    <description>6 months of aerobic exercise training, 3 days per week</description>
    <arm_group_label>T2DM</arm_group_label>
    <arm_group_label>IGT</arm_group_label>
    <arm_group_label>NGT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 50-80

          -  Non-smoker

          -  If woman, postmenopausal &gt;1 year

        Exclusion Criteria:

          -  History of heart disease or stroke

          -  Cancer

          -  Poorly controlled hypertension or dyslipidemia

          -  Kidney or Liver diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kim Dormer, MS</last_name>
    <phone>410-605-7000</phone>
    <phone_ext>4130</phone_ext>
    <email>kimberly.dormer@va.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>Baltimore VA Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Dormer, MS</last_name>
      <phone>410-605-7000</phone>
      <phone_ext>4130</phone_ext>
      <email>kimberly.dormer@va.gov</email>
    </contact>
    <investigator>
      <last_name>Steven J Prior, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2010</study_first_submitted>
  <study_first_submitted_qc>August 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2010</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baltimore VA Medical Center</investigator_affiliation>
    <investigator_full_name>Steven J. Prior, Ph.D.</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

